Physician profile
Richard Graham
NPI 1225092794
$2,964.17
in general payments reported to CMS, 2019-2025
18 companies · $928 in 2025
The $928 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.00 · 2021: $273 · 2022: $761 · 2023: $785 · 2024: $161 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,148 · Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,148.30 |
| Food and Beverage | $725.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,680.41 | 2021-2025 | Urolift, Barrigel |
| Abbvie INC. | $202.73 | 2022-2023 | |
| Blue Earth Diagnostics | $189.19 | 2021-2023 | |
| Astellas Pharma US INC | $154.99 | 2019-2021 | |
| Boston Scientific Corporation | $124.56 | 2021-2025 | Rezum Generator, Ams 700 |
| Antares Pharma, INC. | $122.14 | 2022 | |
| Laborie Medical Technologies Corp. | $82.19 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $76.74 | 2022-2024 | Speedicath |
| Merck Sharp & Dohme LLC | $55.18 | 2022-2023 | Keytruda, Lynparza, Welireg |
| Sumitomo Pharma America, INC. | $47.10 | 2023-2024 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $40.18 | 2023 | |
| Endo Pharmaceuticals INC. | $37.99 | 2022 | |
| Axonics, INC. | $37.14 | 2023 | Axonics |
| Novartis Pharmaceuticals Corporation | $30.76 | 2022 | |
| Ambu INC. | $25.67 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $21.85 | 2023 | Pylarify |
| Urovant Sciences INC | $20.08 | 2022 | |
| Innovation Technologies INC | $15.27 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.